July 19, 2011
A Delaware federal judge on Monday moved three declaratory judgment and antitrust suits filed by Human Genome Sciences Inc. against Genentech Inc. to California, ruling a California judge's expertise with a patent-in-suit outweighs HGS' desire to keep the cases in Delaware.
January 27, 2011
Human Genome Sciences Inc. has filed suit against Genentech Inc. and cancer center City of Hope, seeking a declaration that a patent assigned to the defendants is invalid and not infringed by lupus drug Benlysta.